Submit Deal

Announced

1 Jun 2022

Shin Nippon Biomedical Laboratories to acquire Ina Research for $21m.

Synopsis

Shin Nippon Biomedical Laboratories, a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies, agreed to acquire Ina Research, a Japan-based company mainly engaged in the contract testing and environmental business, for $21m.

Principals

target

Ina Research

bidder

Shin Nippon Biomed Lab

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (4)

kentaro matsuzaki

Board Member at INA RESEARCH INC

Manager

target

Deal

£ 20 M

Total Value

yoshikazu ashibe

Independent Outside Director at INA RESEARCH INC

Manager

target

Deal

£ 20 M

Total Value

hisako sato

Independent Outside Director at INA RESEARCH INC

Manager

target

Deal

£ 20 M

Total Value

masatoshi urano

Supervisory board member at INA RESEARCH INC

Manager

target

Deal

£ 20 M

Total Value

Bidder Team (2)

shinji nitanda

CFO at SHIN NIPPON BIOMED LAB

Manager

bidder

Deals

£ 197 M

Total Value

ryoichi nagata

CEO at SHIN NIPPON BIOMED LAB

Manager

bidder

Deals

£ 197 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy